Baidu
map

Pharmacol Res:“清肺排毒汤”用于新冠肺炎,患者康复率超90%

2020-12-16 MedSci原创 MedSci原创

“清肺排毒汤”应急项目组开展的一项临床研究成果在国际期刊上发表。该研究显示,“清肺排毒汤”是治疗新冠肺炎的有效措施,且早期干预能够获得更好的临床结局。在

“清肺排毒汤”应急项目组开展的一项临床研究成果在国际期刊上发表。该研究显示,“清肺排毒汤”是治疗新冠肺炎的有效措施,且早期干预能够获得更好的临床结局。在新冠肺炎第六版、第七版、第八版国家诊疗方案中,“清肺排毒汤”是唯一一个治疗轻型、普通型、重型和危重型患者的通用方剂,在全国28个省(区、市)得到广泛使用,也是湖北、武汉抗疫主战场,以及援助国际抗疫和治疗输入性病例使用量最大、效果最好的中药方剂。见报道:清肺排毒汤治愈出院率达99.28%,堪称新冠肺炎的特效药中医药有效方剂筛选——清肺排毒汤治疗新冠病毒有效率达90%

此项成果为中医药救治新冠肺炎患者的良好疗效提供了坚实的证据。最初结果发表于2020年7月31日在《柳叶刀》预印版平台,最终发表在《Pharmacological Research》(IF:5.893)杂志上。

此项研究为大样本多中心回顾性队列研究,共纳入中国9个省份54家医院782例新冠肺炎住院患者的数据。所有患者均在使用西药的基础上按《新型冠状病毒肺炎诊疗方案(试行第七版)》使用“清肺排毒汤”进行治疗。根据首次临床症状出现至开始使用“清肺排毒汤”的时间,将患者分为≤1周组(≤7天)、2周组(>7天和≤14天)、3周组(>14天和≤21天)和>3周组(>21天),以探讨“清肺排毒汤”治疗时间早晚与临床结局改善的关系。

研究结果发现, 在轻型、普通型患者和重症、危重型患者中,早期使用“清肺排毒汤”可显著改善临床痊愈时间、临床痊愈率及核酸转阴天数、病程时间等指标。与首次出现症状3周后给予“清肺排毒汤”治疗相比,早期使用“清肺排毒汤”治疗的患者临床痊愈时间显著缩短2-3倍(≤1周组vs >3周组=3.81, 95% CI: 2.65-5.48; 2周组vs >3周组=2.63, 95% CI: 1.86-3.73; 3周组vs >3周组=1.92, 95% CI: 1.34-2.75);病毒核酸转阴中位时间分别从17天依次递减为13天、12天、12天(P = 0.0137);病程中位时间从34天依次递减为24天、21天和18天(P < 0.0001);住院中位时间由18天依次递减为15天、15天、14天(P < 0.0001)。

最终715例(91%)康复,37例(5%)继续治疗,28例(4%)病人加重转入上级医院或ICU治疗,2例死亡。

Fig. 2Kaplan-Meier plot for the primary outcome of time to recovery in patients infected with coronavirus disease 2019 by time from the onset of symptoms to treatment groups with 95 % CIs. 

 

梅斯医学小编点评:

这是一项大型回顾性研究,但是详细读文章,文章的数据详实,但是文章整体设计与写作,与顶级文章相比,还存在较大差距,如果当时进行适当的完善,可能能发表在顶级期刊。

1、这项是回顾性研究,但是给人感觉象是前瞻性设计,不少病人因为数据缺失被排除,这是可惜的。这部分病人可能被质疑“效果不好”,或“效果太好”,从而影响整体的结果判断。

2、文章中虽然说病人使用了清肺排毒汤,但是并没有说明患者使用清肺排毒汤的时间的数据。从《新型冠状病毒肺炎诊疗方案(试行第六版)》来看,3天一个疗程,第二个疗程根据实际情况决定,意味着可能每个病人使用时间可能不一致。病人如果一直在院,是否持续使用清肺排毒汤?另外,一些重症病人,也是使用2个疗程,还是更长时间?这些信息,十分关键,但是文章中漏了。

3、对照与分组。因为特殊原因,所有病人都应用了清肺排毒汤,意味着缺少对照组(不使用清肺排毒汤),因此,给对照带来困难。因此,研究者采用按发病的起始时间进行分组。事实上,作为回顾性研究,可以并不需要一开始就分组,可以观察患者整体的康复状况,以及按使用清肺排毒汤的时间长短来分组,可能都更为合理。而发病到就诊时间,或按轻中重度分型,均可以作为亚组分析,这样似乎更为合理和清晰。

4、数据报告。从生存曲线上看,4组患者中位恢复时间为19-35天。但是,患者入组 时间为January 21, 2020 to March 10, 2020. 最后随访时间为 March 17, 2020,意味着有相当多患者是不够随访时间的(即未恢复即结束随访,至少最后一例随访时间仅7天)。这些信息同样需要详细报告。另外,最终715例(91%)康复,5%继续治疗,28例(4%)病人加重,2例死亡。这里面继续治疗是常规的治疗还是也包括清肺排毒汤的治疗?相对来说交待不太清楚。

总的来说,在当时高度紧张的环境下,能开展这样的临床研究,已相当不容易。虽然国际上对中医中药认可度仍然偏低(另一个原因在于中医中药没有普及),因此,能将文章发表出来,着实不太容易,最终也有较好的发表,这是可喜可贺的。当然,如果能有更高水平期刊的发表,国际影响力会大幅度增加,有利于推动中医中药的发展。

原始出处:

Shi N, Liu B, Liang N, Ma Y, Ge Y, Yi H, Wo H, Gu H, Kuang Y, Tang S, Zhao Y, Tong L, Liu S, Zhao C, Chen R, Bai W, Fan Y, Shi Z, Li L, Liu J, Gu H, Zhi Y, Wang Z, Li Y, Li H, Wang J, Jiao L, Tian Y, Xiong Y, Huo R, Zhang X, Bai J, Chen H, Chen L, Feng Q, Guo T, Hou Y, Hu G, Hu X, Hu Y, Huang J, Huang Q, Huang S, Ji L, Jin H, Lei X, Li C, Wu G, Li J, Li M, Li Q, Li X, Liu H, Liu J, Liu Z, Ma Y, Mao Y, Mo L, Na H, Wang J, Song F, Sun S, Wang D, Wang M, Wang X, Wang Y, Wang Y, Wu W, Wu L, Xiao Y, Xie H, Xu H, Xu S, Xue R, Yang C, Yang K, Yang P, Yuan S, Zhang G, Zhang J, Zhang L, Zhao S, Zhao W, Zheng K, Zhou Y, Zhu J, Zhu T, Li G, Wang W, Zhang H, Wang Y, Wang Y.Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study. Pharmacol Res . 2020 Nov 9;105290. doi: 10.1016/j.phrs.2020.105290

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2021-06-03 jj000001
  4. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2021-07-31 yb6560
  5. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-27 ms1000002008968327

    点评的好,学习了。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-22 122c47aem76暂无昵称

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-16 ms5000000518166734

    已读,受益匪浅

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-15 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1788412, encodeId=4d5a1e8841240, content=<a href='/topic/show?id=38e014162e2' target=_blank style='color:#2F92EE;'>#Pharmacol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14162, encryptionId=38e014162e2, topicName=Pharmacol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Wed Apr 21 11:16:22 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1908616, encodeId=eda21908616f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14160, encryptionId=a8d0141605e, topicName=pharma)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Thu Jul 15 21:16:22 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1787696, encodeId=cbfc1e87696d4, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14159, encryptionId=fa03141591e, topicName=Pharm)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Thu Jun 03 02:16:22 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1996387, encodeId=37d4199638e3a, content=<a href='/topic/show?id=ed881120ec8' target=_blank style='color:#2F92EE;'>#MAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11207, encryptionId=ed881120ec8, topicName=MAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b65161, createdName=yb6560, createdTime=Sat Jul 31 02:16:22 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911239, encodeId=a04091123935, content=点评的好,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=128c5444630, createdName=ms1000002008968327, createdTime=Sun Dec 27 14:01:19 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910167, encodeId=b7a091016ef0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54b82357508, createdName=122c47aem76暂无昵称, createdTime=Tue Dec 22 20:04:10 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908558, encodeId=b81a908558ac, content=已读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Dec 16 14:36:56 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028884, encodeId=f806102888490, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Dec 15 12:16:22 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908127, encodeId=f1c090812eda, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>,<a href='/topic/show?id=4dbe6625408' target=_blank style='color:#2F92EE;'>#清肺排毒汤#</a>,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加<a href='/topic/show?id=4365e5104f1' target=_blank style='color:#2F92EE;'>#积分#</a>更多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=66254, encryptionId=4dbe6625408, topicName=清肺排毒汤), TopicDto(id=75104, encryptionId=4365e5104f1, topicName=积分)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue Dec 15 10:33:25 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-15 仁心济世

    #新冠肺炎#,#清肺排毒汤#,值得读一读,文章发表其实可以更好! 悄悄告诉大家:另外,带话题的评论,加#积分#更多!

    0

相关资讯

2020年12月14日全球新冠肺炎(COVID-19)疫情简报,确诊超7259万,全球各家疫苗订单与订价如何?

Worldometers世界实时统计数据显示,截至北京时间11月14日7时21分,全球新冠肺炎(COVID-19)累计确诊病例超过7259万例,新增500,727例,达到72,592,974例,累计死

2020年12月10日全球新冠肺炎(COVID-19)疫情简报,确诊超6917万,过敏人群慎重接种辉瑞疫苗

Worldometers世界实时统计数据显示,截至北京时间11月10日7时25分,全球新冠肺炎(COVID-19)累计确诊病例超过6917万例,新增608,779例,达到69,178,137例,累计死

NEJM:NVX-CoV2373疫苗表现出良好的安全性及免疫效果

NVX-CoV2373疫苗是安全的,其诱导接种者的免疫反应水平超过了Covid-19患者恢复期血清抗体水平,添加Matrix-M1佐剂后,诱导的CD4+T细胞反应偏向Th1表型

2020年12月13日全球新冠肺炎(COVID-19)疫情简报,确诊超7208万,美国继英国之后批准新冠疫苗上市

Worldometers世界实时统计数据显示,截至北京时间11月13日9时21分,全球新冠肺炎(COVID-19)累计确诊病例超过7208万例,新增635,547例,达到72,089,761例,累计死

2020年12月11日全球新冠肺炎(COVID-19)疫情简报,确诊超7065万,阿联酋正式批准中国新冠疫苗投入使用

Worldometers世界实时统计数据显示,截至北京时间11月11日7时05分,全球新冠肺炎(COVID-19)累计确诊病例超过7065万例,新增636,732例,达到70,657,646例,累计死

2020年12月12日全球新冠肺炎(COVID-19)疫情简报,确诊超7141万,今冬节日可能成为灾难日

Worldometers世界实时统计数据显示,截至北京时间11月12日9时01分,全球新冠肺炎(COVID-19)累计确诊病例超过7141万例,新增695,494例,达到71,412,725例,累计死

Baidu
map
Baidu
map
Baidu
map